Annual CFI
$41.43 M
+$15.03 M+56.92%
31 December 2023
Summary:
Tango Therapeutics annual cash flow from investing activities is currently $41.43 million, with the most recent change of +$15.03 million (+56.92%) on 31 December 2023. During the last 3 years, it has risen by +$186.89 million (+128.48%). TNGX annual CFI is now at all-time high.TNGX Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
$32.57 M
+$19.87 M+156.48%
30 September 2024
Summary:
Tango Therapeutics quarterly cash flow from investing activities is currently $32.57 million, with the most recent change of +$19.87 million (+156.48%) on 30 September 2024. Over the past year, it has increased by +$89.23 million (+157.48%). TNGX quarterly CFI is now -8.24% below its all-time high of $35.49 million, reached on 30 June 2022.TNGX Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
$67.92 M
+$89.23 M+418.62%
30 September 2024
Summary:
Tango Therapeutics TTM cash flow from investing activities is currently $67.92 million, with the most recent change of +$89.23 million (+418.62%) on 30 September 2024. Over the past year, it has increased by +$72.95 million (+1449.99%). TNGX TTM CFI is now -2.51% below its all-time high of $69.67 million, reached on 31 March 2023.TNGX TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TNGX Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +56.9% | +157.5% | +1450.0% |
| 3 y3 years | +128.5% | +121.4% | +149.1% |
| 5 y5 years | - | - | - |
TNGX Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +122.6% | -8.2% | +121.4% | -2.5% | +131.5% |
| 5 y | 5 years | at high | +122.6% | -8.2% | +121.4% | -2.5% | +131.5% |
| alltime | all time | at high | +122.6% | -8.2% | +121.4% | -2.5% | +131.5% |
Tango Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $32.57 M(+156.5%) | $67.92 M(-418.6%) |
| June 2024 | - | $12.70 M(-213.4%) | -$21.32 M(+1505.1%) |
| Mar 2024 | - | -$11.20 M(-133.1%) | -$1.33 M(-103.2%) |
| Dec 2023 | $41.43 M(+56.9%) | $33.85 M(-159.7%) | $41.43 M(-923.4%) |
| Sept 2023 | - | -$56.66 M(-273.4%) | -$5.03 M(-107.5%) |
| June 2023 | - | $32.69 M(+3.6%) | $66.86 M(-4.0%) |
| Mar 2023 | - | $31.55 M(-350.3%) | $69.67 M(+163.9%) |
| Dec 2022 | $26.40 M | -$12.61 M(-182.8%) | $26.40 M(-525.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | $15.23 M(-57.1%) | -$6.20 M(-96.4%) |
| June 2022 | - | $35.49 M(-402.9%) | -$173.65 M(-19.5%) |
| Mar 2022 | - | -$11.72 M(-74.1%) | -$215.76 M(+17.6%) |
| Dec 2021 | -$183.43 M(+26.1%) | -$45.21 M(-70.3%) | -$183.43 M(+32.7%) |
| Sept 2021 | - | -$152.21 M(+2197.6%) | -$138.23 M(-1088.3%) |
| June 2021 | - | -$6.63 M(-132.1%) | $13.99 M(-32.1%) |
| Mar 2021 | - | $20.61 M | $20.61 M |
| Dec 2020 | -$145.47 M | - | - |
FAQ
- What is Tango Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Tango Therapeutics?
- What is Tango Therapeutics annual CFI year-on-year change?
- What is Tango Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Tango Therapeutics?
- What is Tango Therapeutics quarterly CFI year-on-year change?
- What is Tango Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Tango Therapeutics?
- What is Tango Therapeutics TTM CFI year-on-year change?
What is Tango Therapeutics annual cash flow from investing activities?
The current annual CFI of TNGX is $41.43 M
What is the all time high annual CFI for Tango Therapeutics?
Tango Therapeutics all-time high annual cash flow from investing activities is $41.43 M
What is Tango Therapeutics annual CFI year-on-year change?
Over the past year, TNGX annual cash flow from investing activities has changed by +$15.03 M (+56.92%)
What is Tango Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of TNGX is $32.57 M
What is the all time high quarterly CFI for Tango Therapeutics?
Tango Therapeutics all-time high quarterly cash flow from investing activities is $35.49 M
What is Tango Therapeutics quarterly CFI year-on-year change?
Over the past year, TNGX quarterly cash flow from investing activities has changed by +$89.23 M (+157.48%)
What is Tango Therapeutics TTM cash flow from investing activities?
The current TTM CFI of TNGX is $67.92 M
What is the all time high TTM CFI for Tango Therapeutics?
Tango Therapeutics all-time high TTM cash flow from investing activities is $69.67 M
What is Tango Therapeutics TTM CFI year-on-year change?
Over the past year, TNGX TTM cash flow from investing activities has changed by +$72.95 M (+1449.99%)